Our results show for the first time the phenotypic correction of primary HSPCs from FA‐A patients by means of the specific insertion of a therapeutic FA gene into a “safe harbor” locus, thus minimizing risks of insertional oncogenesis. Here, FANCA is linked to Friedreich ataxia.